Add eLife assessment to a reviewed preprint example

elifesciences/issues#9034

data/reviewed-preprints/09560.json

@@ -46,5 +46,22 @@
       }
     }
   },
+  "elifeAssessment": {
+    "title": "eLife assessment",
+    "id": "sa0",
+    "doi": "10.7554/eLife.09562.sa00",
+    "content": [
+      {
+        "type": "paragraph",
+        "text": "Collagen is a major component of extracellular matrix. The authors have identified a high-affinity inhibitory collagen receptor LAIR-1 and a soluble decoy receptor LAIR-2 (with even higher binding affinity to collagen), which can be therapeutically targeted to block tumor progression. Dr Meyaard and colleagues have also generated a dimeric LAIR-2 human IgG1 Fc fusion protein NC410 for therapeutic use. With humanized mouse models engrafted with functional human immune systems (PBMC), they have explored the anti-cancer efficacy of NC410 and revealed its impact on modulating immune responses. Furthermore, they extended this study to identify biomarkers of predictive value for NC410-based anti-cancer therapy."
+      }
+    ],
+    "significance": [
+      "important"
+    ],
+    "strength": [
+      "solid"
+    ]
+  },
   "version": 1
 }